| Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis | |
| Li, Lin; Zhao, Wenzhuo; Wang, Mengmeng; Hu, Jie; Wang, Enxin; Zhao, Yan; Liu, Lei | |
| 刊名 | BMC GASTROENTEROLOGY
 |
| 2018 | |
| 卷号 | 18 |
| 关键词 | Transarterial chemoembolization Sorafenib Meta-analysis Hepatocellular carcinoma Systemic review |
| ISSN号 | 1471-230X |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/2920193 |
| 专题 | 西安交通大学 |
| 推荐引用方式 GB/T 7714 | Li, Lin,Zhao, Wenzhuo,Wang, Mengmeng,et al. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis[J]. BMC GASTROENTEROLOGY,2018,18. |
| APA | Li, Lin.,Zhao, Wenzhuo.,Wang, Mengmeng.,Hu, Jie.,Wang, Enxin.,...&Liu, Lei.(2018).Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.BMC GASTROENTEROLOGY,18. |
| MLA | Li, Lin,et al."Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis".BMC GASTROENTEROLOGY 18(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论